COVID-19: UK reports 53,945 new cases and 141 more deaths in highest daily infection figure since post-Euro rally in July | UK news

The United Kingdom recorded 53,945 new cases of coronavirus – the highest daily number since mid-July after the European Football Championship.

The last time more cases were reported was on July 17 when the number of new cases reached 54,674 COVID-19 Cases were recorded, six days after the tournament final at Wembley.

Public Health England previously said England’s deep run in competition – losing to Italy on penalties in the final – was linked to that. More than 9000 new cases of corona virus.

Follow the latest COVID updates in the UK and around the world

Please use Chrome browser for an accessible video player

In-lab testing of the Omicron “first district” variant

Thursday’s data also showed 141 more deaths within 28 days of the positive case Corona Virus Test – compared to 41 on July 17.

At this time last week, there were 147 deaths and 47,240 new cases of infection.

Meanwhile, another 26,028 people have received the COVID vaccine, bringing the UK’s total to 51,020,285.

And 32,356 others got a second dose, which means that the number of those who have been double stabbed is now 464,31662.

Another 407,851 doses of the booster or third vaccine were given, meaning that 19015975 — or 33.1% of the population over 12 years of age — got an extra dose.

It comes as health officials announce that a new treatment for COVID – sotrovimab – has been introduced. Approved for use in the UK.

The Medicines and Healthcare products Regulatory Agency (MHRA) said trials showed the drug reduced the risk of hospitalization or death by 79%.

Follow the daily podcast on apple podcast, google podcast, spotify, speaker

Developed by London-based GlaxoSmithKline in conjunction with California-based Vir Biotechnology – the makers of the preclinical data say the drug “retains activity against key mutations of the new Omicron variant”.

join Ronabrev And Molnopiravir As a treatment for covid.

Write a Comment